
Company profile · Onderzoeks- & kennisinstelling
Advanced X-ray Tomographic Imaging Lab
- Research
- Onderzoeks- & kennisinstelling
- Nijmegen
- Research · Nijmegen
- Employees
- 11–50
- Founded
- 2015
- Province
- Gelderland
- Country
- Netherlands
About Advanced X-ray Tomographic Imaging Lab
Medical physics and biomedical engineering research at the Advanced X-ray Tomographic Imaging (AXTI, homophone of actie, meaning action in Dutch) lab focuses on novel image acquisition, processing and analysis techniques, physical and perceptual evaluation of image quality, radiation dosimetry, tomographic image reconstruction, and advanced computational simulation methods in diagnostic x-ray based imaging, especially for breast and body tomographic imaging.
The aim of the AXTI lab is to perform state-of-the-art, clinically relevant research by working side by side with clinicians from the Department of Medical Imaging at Radboudumc and collaborating with commercial partners, medical physicists, and scientists from around the world.
Keywords
- Advanced Computational Simulation Methods
- Biomedical Engineering
- Breast Cancer
- Breast Ct
- Digital Breast Tomosynthesis
- Image Reconstruction
- Machine/Deep Learning
- Medical Imaging Analysis
- Medical Physics
- Novel Image Acquisitions
- Processing And Analysis Techniques
- Radiation Dosimetry
- Research
Address
Headquarters
Geert Grooteplein 106525GA NijmegenGelderland, Netherlands
Team by function
Based on 7 public job profiles as of 4 September 2026.
- Research / R&D7
Similar companies
Companies with a similar profile, Gelderland first.

3D Lab Radboudumc
Hospital & Health Care · Nijmegen
11–50 employeesView profile

X-omics
Hospital & Health Care · Nijmegen
51–200 employeesView profile

ATRO Medical BV
Medical Devices · Nijmegen
2–10 employeesView profile

DYNAMIC
Research · Nijmegen
11–50 employeesView profile

Artinis Medical Systems
Biotechnology · Elst
11–50 employeesView profile

Biomedical Imaging Group Rotterdam
Biotechnology · Rotterdam
51–200 employeesView profile